Talis Biomedical (NASDAQ: TLIS)
$9.00
(-2.2%)
-$0.20
Price as of April 25, 2024, 3:13 p.m. ET
Talis Biomedical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Talis Biomedical Company Info
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Redwood City, CA.
News & Analysis
Valuation
Earnings Transcripts
Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript
TLIS earnings call for the period ending March 31, 2022.
Motley Fool Transcribing | May 11, 2022
Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Transcript
TLIS earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Mar 15, 2022
Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Call Transcript
TLIS earnings call for the period ending September 30, 2021.
Motley Fool Transcribing | Nov 16, 2021
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.